List view / Grid view
Warnings about addiction will be added to the patient information leaflets of opioids, the MHRA has announced.
An international team of researchers has used nanoparticles to deliver a drug – one that previously failed in clinical trials for pain – into specific compartments of nerve cells, dramatically increasing its ability to treat pain in mice and rats. Nikki Withers spoke to Nigel Bunnett to hear more about…
Purdue Pharma is to reimburse the legal fees for states that backed its proposed $10 billion settlement of opioid lawsuits, but with a condition meant to help victims of the addiction crisis.
Researchers have used nanoparticles to infuse a non-opioid drug into nerves to provide enhanced pain relief.
Teva has agreed to supply opioid medication and make a cash payment in a settlement agreement that removes it from the Track 1 opioid litigation.
Drugmakers that face litigation over the opioid crisis are looking at ways to settle the cases by using Purdue's bankruptcy, it has been reported.
The pharmaceutical company is planning to appeal the decision to pay the state for damages relating to the US opioid crisis.
Teva has agreed to pay Oklahoma, resolving allegations that illegal marketing of its medication contributed to the state’s opioid epidemic.
The US government has filed criminal charges against Rochester Drug Co-Operative (RDC), one of the largest pharmaceutical distribution companies in the US, and its former CEO Laurence Doud III and former Chief of Compliance Officer, William Pietruszewski.
Combining benzodiazepines, opioids and Z-drugs could prove to cause serious adverse outcomes including breathing problems and fatalities...
Initiating an opioid analgesic reduced the use of antipsychotics and benzodiazepines in persons with Alzheimer's disease...